latest news releases from the newsroom
IP NetTech AG
IP NetTech AG launches Revolutionary Enterprise IP Communication Solution
TAEGERWILEN, Switzerland, Jan. 6, 2004 (PRIMEZONE) -- IP NetTech AG announces the launch of its Enterprise IP Communication solution, ipcom360(tm)1.0. ipcom360(tm) allows businesses to hold real-time communications with clients, partners and colleagues in complete privacy by combining real time voice, web conferencing, video, instant messaging, and integration into Communication enabled Business Processes.
Scott Bowers Promoted to Vice President of Marketing Worldwide
FOOTHILL RANCH, Calif., Jan. 6, 2004 (PRIMEZONE) -- Oakley, Inc. (NYSE:OO) today announced that Scott Bowers, Vice President of Sports Marketing, has been promoted to the newly created position of Vice President of Marketing Worldwide. In his new role, Mr. Bowers will be responsible for overseeing worldwide all aspects of Oakley's marketing programs, including sports marketing, advertising and Oakley's consumer marketing campaigns.
MEDIA ADVISORY -- CEVA to Present at Needham Growth Conference
DUBLIN, Jan. 6, 2004 (PRIMEZONE) -- Media Advisory -- CEVA, Inc. (Nasdaq:CEVA) (LSE:CVA), the industry's leading licensor of Digital Signal Processor (DSP) cores and solutions to the semiconductor industry, today announced that Chet Silvestri, CEO, and Christine Russell, CFO, will be present at the sixth annual Needham Growth Conference on Friday, January 9th, at the New York Palace Hotel, New York.
Humana Trans Unit Signs Definitive Acquisition Agreement
HANOVER, Md., Jan. 6, 2004 (PRIMEZONE) -- Humana Trans Services Holding Corporation (OTCBB:HTSC) (www.humanaservices.com), a principally engaged firm involved in employee leasing and recruitment services, is pleased to announce that the firm's operating subsidiary Humana National Program Administrators has proceeded on its intention to acquire Stratford, CT.-based Personnel Management Solutions, a firm involved in temp-to-perm staffing and payroll administration.
Celltech Group plc
Celltech Group plc Announces Initiation of CDP870 Phase III Trials in Crohn's Disease
SLOUGH, U.K., Jan. 5, 2004 (PRIMEZONE) -- Celltech Group plc (LSE:CCH) (NYSE:CLL) today announces that it commenced dosing of patients in the first of two pivotal Phase III studies ("PRECISE-1") for CDP870 in Crohn's disease on 23 December 2003, following its U.S. investigator meeting held on 22 November. The second pivotal study ("PRECISE-2 ") is scheduled to start in January 2004, with regulatory submissions planned for 2005. Celltech intends to market CDP870 in Crohn's disease using its gastroenterology focused sales force in the US and specialist focused sales forces in Europe.
Discovery Laboratories, Inc.
Discovery Laboratories to Present at the 22nd Annual JP Morgan Healthcare Conference
DOYLESTOWN, Pa., Jan. 5, 2004 (PRIMEZONE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO), a biopharmaceutical company developing its proprietary surfactant technology as Surfactant Replacement Therapies for respiratory diseases, today announced that Robert J. Capetola, Ph.D., President and Chief Executive Officer of Discovery, will provide an update on the company's progress during the 22nd Annual JP Morgan Healthcare Conference in San Francisco. The conference will be simultaneously webcast over the Internet.